Peterfi, L., Yusenko, M. V., Kovacs, G., & Beothe, T. (2024). Lack of VEGFA/KDR signaling in conventional renal cell carcinoma explains the low efficacy of target therapy and frequent adverse events. International journal of molecular sciences, 25(13), . https://doi.org/10.3390/ijms25137359
Chicago-Zitierstil (17. Ausg.)Peterfi, Lehel, Maria V. Yusenko, Gyula Kovacs, und Tamas Beothe. "Lack of VEGFA/KDR Signaling in Conventional Renal Cell Carcinoma Explains the Low Efficacy of Target Therapy and Frequent Adverse Events." International Journal of Molecular Sciences 25, no. 13 (2024). https://doi.org/10.3390/ijms25137359.
MLA-Zitierstil (9. Ausg.)Peterfi, Lehel, et al. "Lack of VEGFA/KDR Signaling in Conventional Renal Cell Carcinoma Explains the Low Efficacy of Target Therapy and Frequent Adverse Events." International Journal of Molecular Sciences, vol. 25, no. 13, 2024, https://doi.org/10.3390/ijms25137359.